H-RMSAPSTGGV-OH

Ref. 3D-PP42725

Información del producto

• Nombre: H-RMSAPSTGGV-OH
• Sinónimos: NH2-Arg-Met-Ser-Ala-Pro-Ser-Thr-Gly-Gly-Val-OH

Descripción

Peptide H-RMSAPSTGGV-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RMSAPSTGGV-OH include the following: Novel and shared neoantigen derived from histone 3 variant H3. 3K27M mutation for glioma T cell therapy ZS Chheda , G Kohanbash , K Okada, N Jahan - Journal of Experimental , 2018 - rupress.orghttps://rupress.org/jem/article-abstract/215/1/141/42475 Endogenous H3. 3K27M derived peptide restricted to HLA-A∗ 02: 01 is insufficient for immune-targeting in diffuse midline glioma SS Wang , K Pandey , KA Watson, RC Abbott - Molecular Therapy , 2023 - cell.comhttps://www.cell.com/molecular-therapy-family/oncology/fulltext/S2372-7705(23)00058-X H3. 3K27M mutation is not a suitable target for immunotherapy in HLA-A2+ patients with diffuse midline glioma L Immisch, G Papafotiou , O Popp - for Immunotherapy of , 2022 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621174/ K27M-mutant histone-3 as a novel target for glioma immunotherapy K Ochs, M Ott , T Bunse, F Sahm , L Bunse - , 2017 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/2162402X.2017.1328340

• Marca: Biosynth